Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease

QJM: An International Journal of Medicine

Volumn 89, Issue 1, 1996, Pages 15-23

  Reinhold Keller, E ^a,b   De Groot, K ^a,b   Rudert, H ^c   Nolle B ^c   Heller, M ^c   Gross, W L ^a,b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Rheumaklinik Bad Bramstedt   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; CREATININE; GLUCOCORTICOID; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG EFFICACY; EOSINOPHILIA; FEMALE; HUMAN; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; REMISSION; WEGENER GRANULOMATOSIS;

EID: 0030028966     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.qjmed.a030133     Document Type: Article

References (33)

1. Gross WL. New developments in the treatment of systemic vasculitis. Curr Opin Rheumatol 1994; 6:11-19.
2. Wallon EW. Giant cell granuloma of the respiratory tract (Wegener's granuiomatosis). Br Med J 1958; 2:265-70.
3. DeRemee RA, McDonald TJ, Harrison EG Jr, Coles DT. Wegener's granulomatosis: anatomic correlates, a proposed classification. Mayo Clin Proc 1976; 51:777-81.
4. Gross WL. Wegener's granulomatosis: New aspects of the disease course, immunodiagnostic procedures and stage-adapted treatment. Sarcoidosis 1989; 6:15-29.
5. Hoffman, GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116:488-98.
6. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98:76-85.
7. Gordon M, Luqmani RA, Adu D, Greaves 1, Richards N, Michael J, Emery P, Howie AJ, Bacon PA Relapses in patients with a systemic vasculitis. Q J Med 1993; 86:779-89.
8. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL. Influence of disease manifestation and anineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide in Wegener's granulomatosis. Arthritis Rheum 1994; 37:919-24.
9. Hoffman GS, Leavitt RY, Kerr GS, Fauci AS. The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum 1992; 35:1322-9.
10. DeRemee AR, McDonald TJ, Weiland LH. Wegener's granulomatosis: observation on treatment with antimicrobial agents. Mayo Clin Proc 1985, 60:27-32.
11. DeRemee AR. The treatment of WegenerÛs granulomatosis with Trimethoprim/Sulfamethoxazole: illusion or vision? Arthritis Rheum 1988; 31:1068-72.
12. Leavitt RY, Hoffman GS, Fauci AS. Response: the role of Trimethoprim/Sulfamethoxazote in the treatment of Wegener's granulomatosis. Arthritis Rheum 1988; 31:1073-4.
13. Leavitt RY, Fauci AS, Blich DA, Michel BA, Hunder CG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfolt RW Jr, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33:1101-7.
14. Jennette CJ, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A, Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-92.
15. Nölle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989; 111:28-40.
16. Steppat D, Gross WL. Stage-adapted treatment of Wegener's granulomatosis. Klin Wochenschr 1989; 67:666-71.
17. Asmus R, Muhle C, Koltze H, Spielmann RP, Gross WL, Duncker G, Nolle B, Beigel A. Magnetresonanztomographische Kennzeichen der Wegener'schen Granulomatose im Kopfbereich. Fortschr Röntgenstr 1992; 157:11-14.
18. Schmitt WH, Heesen C, Csernok E, Rautmann A, Gross WL. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis: association with disease activity. Arthritis Rheum 1992; 35:1088-96.
19. West BC, Tood JR, King JW. Wegener granulomatosis and trimethoprim-sulfametnoxazole. Ann Intern Med 1987; 106:840-2.
20. Axelson JA, Clark RH, Ancerewicz S. Wegener granulomatosis and trimethoprim-sulfamethoxazole. Ann Intern Med 1987; 107:600 (letter).
21. Spiera H, Lawson W, Weinrauch H. Wegener's granulomatosis treated with sulfamethoxazole-trimethoprim. Arch Intern Med 1988; 148:2065-6.
22. Israel HL. Sulfamethoxazole-trimethoprim therapy for Wegener's granulomatosis. Arch Intern Med 1988; 148:2293-5.
23. Yuasa K, Tokitsu M, Goto H, Kato H, Shimada K. Wegener's granulomatosis: diagnosis by transbronchial lung biopsy, evaluation by gallium scintigraphy and treatment with suflamethoxazole-titmethoprim. Am J Med 1988; 84:371-2 (letter).
24. Rasmussen N, Petersen J, Remvig L, Andersen V: Treatment of Wegener's granulomatosis with trimethoprim-sulfamethoxazole. APMIS Suppl. 19 1990; 98:61-2.
25. Hoen B, Aymard B, Gerard A, Brunet A, Mertes PM, May TH, Canton PH, Dureux JB. Sulfamethoxazole-trimethoprim (SMZ-TMP) as an effective therapy for Wegener's granulomatosis (WG) - three more cases. APMIS Suppl. 19 1990; 98:65.
26. Puolijoki H, Liippo K, Raitio M, Tala E. Wegener's granulomatosis - treatment under revision? Respiration 1992; 59:116-18.
27. Valeriano-Marcet J, Spiera H. Treatment of Wegener's granulomatosis with sulfamethoxazole-trimethoprim. Arch Intern Med 1991; 151:1649-52.
28. McRae D, Buchanan G. Long-term sulfamethoxazole-trimethoprim in Wegener's granulomatosis. Arch Otolaryngol Head Neck Surg 1993; 119:103-5.
29. Roberts DE and Curd JG. Sulfonamides as antiinflammatory agents in the treatment of Wegener's granulomatosis. Arthritis Rheum 1990; 33:1590-3.
30. Carrington CB, Liebow AA. Limited forms of angiitis and granulomatosis of Wegener's type. Am J Med 1966; 41:497-527.
31. Luqmani RA, Bacon PA, Beaman M, Scott DGI, Emery P, Lee SJ, Howie AJ, Richards N, Michael J, Adu D. Classical versus non-renal Wegener's granulomatosis. Q J Med 1994; 87:161-7.
32. Luquami RA, Bacon PA, Moots, RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculits. Q J Med 1994; 87:671-8.
33. Handrock K, Reinhold-Keller E, Heller M, Rudert H, Duncker G, Gross WL. Beneficial effects of low-dose Methotrexate (MTX) in Wegener's granulomatosis (WG). Arthritis Rheum 1994; 37:353.